Medipost Co Ltd KRX:078160:
MEDIPOST INC. SUBMITS IND AMENDMENT WITH U.S. FOOD AND DRUG ADMINISTRATION TO INITIATE PHASE III TRIAL
MEDIPOST:IND AMENDMENT SUBMITTED TO FDA TO SUPPORT INITIATING PHASE III CLINICAL TRIAL EVALUATING INVESTIGATIONAL CELL THERAPY FOR KNEE OSTEOARTHRITIS